|
|
|
|
| Security Name: |
BIO TECHNOLOGY GENERAL CO |
| Cusip: |
123456789 |
| Realized Gain/Loss: |
N/A |
|
|
| Reference #: |
C123456 |
K12345 |
| Transaction Type: |
TRANSFER IN |
Sale |
| Trade Date: |
N/A |
10/01/1999 |
| Quantity: |
100 |
100 |
| Price: |
$0.00 |
$25.31 |
| Principal: |
$0.00 |
$2,531.25 |
| Commission: |
$0.00 |
$20.00 |
| Interest: |
N/A |
N/A |
| Fees: |
$0.00 |
$0.00 |
| Total Cost/Proceeds: |
$0.00 |
$2,511.16 |
| Amortization: |
N/A |
N/A |
|
|
Cost Basis on fixed income securities is adjusted for amortization, accretion, or principal paydowns. Original cost basis is provided under the corresponding tax lot. This report is prepared on a trade-dated basis, rather than a settlement-dated basis and may be different than your brokerage account statement. Please refer to your monthly brokerage account statement for additional information.
TIAA-CREF Brokerage Services is not authorized to give tax advice. Unrealized and Realized Gain/Loss information is for Cash Solutions Accounts only and should be considered general reference. Cost basis information for securities acquired prior to activation of the tax lot accounting system or for securities delivered into your account after purchase, has been provided to TIAA-CREF Brokerage Services by you. TIAA-CREF Brokerage Services makes no representation as to the accuracy of information provided by clients. Total realized and unrealized gains and losses do not include securities for which no cost basis is available. Note: In the absence of instruction to the contrary, sell transactions will be recorded on a first in first out (FIFO) accounting basis. Cost basis may change in the event of the death of an account owner. Consult your attorney or tax advisor for additional information.
|
|
|
|
